Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

Legal Reader
legalreader.com > law-firms-keep-getting-burned-by-ai-the-fix-isnt-banning-it

Law Firms Keep Getting Burned by AI. The Fix Isn't Banning It.

1+ week, 4+ day ago   (323+ words) The fix isn’t to swear off AI. It’s to stop using tools that guess when the job requires proof. Judges have already caught legal teams citing cases that don’t exist. A brief goes in with a string of citations, the…...

Legal Reader
legalreader.com > law-is-equal-litigation-isnt

The Law Is Equal. Litigation Isn't.

2+ week, 5+ day ago   (670+ words) But after years of trying personal injury cases, I’ve learned that one of the biggest misconceptions about civil litigation is believing the trial itself determines the outcome. Personal injury trial lawyers know better. Jurors rarely see those battles. The public…...

Legal Reader
legalreader.com > appeals-court-revives-6-7-billion-bristol-myers-lawsuit

Appeals Court Revives $6.7 Billion Bristol Myers Lawsuit

3+ week, 3+ day ago   (409+ words) The drugs included Liso-cel, now sold under the name Breyanzi, along with Ozanimod and Ide-cel. Shareholders who held the CVRs became concerned that the drugmaker would not obtain the required approvals in time. If the deadlines were missed, the shareholders…...